Nurix Therapeutics Inc (NRIX)
13.38
-0.58
(-4.15%)
USD |
NASDAQ |
May 10, 13:05
Nurix Therapeutics Price to Book Value: 4.842 for May 10, 2024
Price to Book Value Chart
Historical Price to Book Value Data
| Date | Value |
|---|---|
| May 09, 2024 | 5.052 |
| May 08, 2024 | 5.059 |
| May 07, 2024 | 5.124 |
| May 06, 2024 | 4.784 |
| May 03, 2024 | 4.625 |
| May 02, 2024 | 4.607 |
| May 01, 2024 | 4.734 |
| April 30, 2024 | 4.350 |
| April 29, 2024 | 4.513 |
| April 26, 2024 | 4.473 |
| April 25, 2024 | 4.473 |
| April 24, 2024 | 4.976 |
| April 23, 2024 | 5.113 |
| April 22, 2024 | 4.914 |
| April 19, 2024 | 4.918 |
| April 18, 2024 | 5.226 |
| April 17, 2024 | 5.095 |
| April 16, 2024 | 5.302 |
| April 15, 2024 | 4.503 |
| April 12, 2024 | 4.876 |
| April 11, 2024 | 5.013 |
| April 10, 2024 | 4.57 |
| April 09, 2024 | 5.091 |
| April 08, 2024 | 4.020 |
| April 05, 2024 | 4.049 |
| Date | Value |
|---|---|
| April 04, 2024 | 4.060 |
| April 03, 2024 | 4.250 |
| April 02, 2024 | 4.328 |
| April 01, 2024 | 4.247 |
| March 28, 2024 | 4.282 |
| March 27, 2024 | 4.235 |
| March 26, 2024 | 3.792 |
| March 25, 2024 | 3.941 |
| March 22, 2024 | 3.909 |
| March 21, 2024 | 3.792 |
| March 20, 2024 | 3.867 |
| March 19, 2024 | 3.710 |
| March 18, 2024 | 3.739 |
| March 15, 2024 | 3.809 |
| March 14, 2024 | 4.088 |
| March 13, 2024 | 4.216 |
| March 12, 2024 | 4.187 |
| March 11, 2024 | 4.114 |
| March 08, 2024 | 4.324 |
| March 07, 2024 | 4.222 |
| March 06, 2024 | 4.56 |
| March 05, 2024 | 3.884 |
| March 04, 2024 | 3.919 |
| March 01, 2024 | 3.948 |
| February 29, 2024 | 3.596 |
Price to Book Ratio Definition
Price to book value is a valuation ratio that is measured by stock price / book value per share. The book value is essentially the tangible accounting value of a firm compared to the market value that is shown.
Price to Book Value Range, Past 5 Years
0.8816
Minimum
Oct 25 2023
10.58
Maximum
Aug 19 2020
3.026
Average
2.492
Median
Price to Book Value Benchmarks
| Gilead Sciences Inc | 4.694 |
| ALX Oncology Holdings Inc | 4.322 |
| Vanda Pharmaceuticals Inc | 0.5248 |
| GlycoMimetics Inc | 0.4404 |
| Immunic Inc | 3.861 |
Price to Book Value Related Metrics
| PS Ratio | 9.024 |
| Price | 13.38 |
| Earnings Yield | -19.88% |
| Market Cap | 817.08M |